Tesaro (TSRO) Received New Leerink Swann Rating; Guidance Software (GUID) Has 1.54 Sentiment

November 15, 2017 - By Marguerite Chambers

Guidance Software, Inc. is a technology company. The company has market cap of $236.36 million. The Firm is a well-known provider of endpoint investigation solutions for cybersecurity analytics, security incident response, e-discovery, data privacy and forensic analysis. It currently has negative earnings. The Firm has five divisions, which include Products, Subscription, Professional services, Training and Maintenance.

Among 24 analysts covering Tesaro Inc (NASDAQ:TSRO), 12 have Buy rating, 1 Sell and 11 Hold. Therefore 50% are positive. Tesaro Inc has $23600 highest and $56 lowest target. $155.09’s average target is 76.26% above currents $87.99 stock price. Tesaro Inc had 61 analyst reports since August 24, 2015 according to SRatingsIntel. Robert W. Baird downgraded TESARO Inc (NASDAQ:TSRO) on Monday, February 27 to “Neutral” rating. The stock of TESARO Inc (NASDAQ:TSRO) has “Outperform” rating given on Monday, August 24 by Leerink Swann. The company was initiated on Thursday, March 17 by Citigroup. The rating was maintained by Leerink Swann on Wednesday, August 9 with “Hold”. As per Tuesday, August 30, the company rating was initiated by Bank of America. The stock of TESARO Inc (NASDAQ:TSRO) earned “Hold” rating by Piper Jaffray on Monday, October 23. The firm has “Outperform” rating by FBR Capital given on Wednesday, June 29. The firm has “Outperform” rating given on Wednesday, April 13 by FBR Capital. As per Monday, October 10, the company rating was maintained by RBC Capital Markets. The stock of TESARO Inc (NASDAQ:TSRO) earned “Overweight” rating by Morgan Stanley on Friday, January 13.

Analysts await TESARO Inc (NASDAQ:TSRO) to report earnings on February, 27. They expect $-2.38 EPS, up 8.46% or $0.22 from last year’s $-2.6 per share. After $-0.47 actual EPS reported by TESARO Inc for the previous quarter, Wall Street now forecasts 406.38% negative EPS growth.

TESARO, Inc. is an oncology-focused biopharmaceutical company. The company has market cap of $4.72 billion. The Firm operates through the business of developing and commercializing of oncology-focused therapeutics segment. It currently has negative earnings. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

About 3,200 shares traded. TESARO Inc (NASDAQ:TSRO) has risen 254.28% since November 15, 2016 and is uptrending. It has outperformed by 237.58% the S&P500.

Investors sentiment increased to 1.46 in Q2 2017. Its up 0.06, from 1.4 in 2017Q1. It increased, as 38 investors sold TESARO Inc shares while 70 reduced holdings. 73 funds opened positions while 85 raised stakes. 55.42 million shares or 0.39% more from 55.21 million shares in 2017Q1 were reported. Vanguard Grp owns 2.98 million shares for 0.02% of their portfolio. Greenwood Capital Limited Com reported 1,895 shares or 0.07% of all its holdings. Daiwa Secs Grp Inc invested in 0.02% or 19,125 shares. Nomura invested in 0% or 7,200 shares. 255 were accumulated by Huntington Natl Bank. Venbio Select Advisor Limited Liability Corp reported 7.07% stake. Great West Life Assurance Com Can owns 9,620 shares. Pictet Asset Mgmt has 399,105 shares for 0.18% of their portfolio. Old Mutual Customised Solutions (Proprietary) Limited accumulated 700 shares. Moreover, Hillhouse Mngmt has 0.06% invested in TESARO Inc (NASDAQ:TSRO) for 29,697 shares. Westfield Capital Mngmt Company Ltd Partnership holds 56,641 shares. Illinois-based Pentwater Capital Mngmt Ltd Partnership has invested 0.03% in TESARO Inc (NASDAQ:TSRO). Spark Inv Mngmt Ltd Liability Corp owns 38,700 shares for 0.33% of their portfolio. Gam Ag accumulated 0.03% or 16,086 shares. 381 were accumulated by Us Comml Bank De.

Since June 6, 2017, it had 0 insider buys, and 1 insider sale for $1.18 million activity. 8,500 shares valued at $1.18 million were sold by English Edward C on Tuesday, June 6.

Ratings analysis reveals 100% of Guidance Software’s analysts are positive. Out of 5 Wall Street analysts rating Guidance Software, 5 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $7.0 while the high is $10.0. The stock’s average target of $8.38 is 18.53% above today’s ($7.07) share price. GUID was included in 5 notes of analysts from November 11, 2016. The stock has “Outperform” rating by Imperial Capital on Friday, November 11. On Wednesday, November 16 the stock rating was initiated by Roth Capital with “Buy”. The stock of Guidance Software, Inc. (NASDAQ:GUID) has “Buy” rating given on Tuesday, February 14 by Benchmark. Piper Jaffray initiated it with “Overweight” rating and $8.5 target in Wednesday, April 5 report. Northland Capital initiated Guidance Software, Inc. (NASDAQ:GUID) rating on Monday, April 10. Northland Capital has “Outperform” rating and $8.0 target.

Rgm Capital Llc holds 1.82% of its portfolio in Guidance Software, Inc. for 2.71 million shares. Tensile Capital Management Llc owns 1.30 million shares or 1.74% of their US portfolio. Moreover, Herald Investment Management Ltd has 1.02% invested in the company for 449,960 shares. The Connecticut-based Bourgeon Capital Management Llc has invested 0.43% in the stock. Tfs Capital Llc, a Pennsylvania-based fund reported 153,864 shares.

It closed at $7.07 lastly. It is down 25.34% since November 15, 2016 and is uptrending. It has outperformed by 8.64% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 6 selling transactions for $1.49 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marguerite Chambers




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: